Adem ATACAK

Dr. Adem ATACAK

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2026 in Anatolian Current Medical Journal
Verified
Journal Article
Open access
Omer UnalOmer Unal
Omer Unal
AAAdem ATACAK
Adem ATACAK
EMElif Gülbahçe Mutlu
Elif Gülbahçe Mutlu
Aims: This study aimed to evaluate the effects of intraperitoneal zinc (Zn) supplementation on hepatic structural alterations, enzymatic antioxidant capacity, and metabolic regulation in an aged diabetic rat model.Methods: Female rats aged 18 months type 2 diabetes mellitus (T2DM) was induced using a high-fat diet (HFD) and streptozotocin (STZ). The STZ+Zn group received 5 mg/kg/day of Zn sulphate intraperitoneally. Histomorphometric and histochemical evaluations of liver tissue were performed, including assessment of the N/C ratio and sinusoidal dilation, as well as staining with Masson and PAS. Immunohistochemistry was used to analyse protein levels (PGC1α, FTO), while qPCR was employed to examine mRNA expression (HO-1, CAT).Results: Significant improvements in sinusoidal dilatation, increased N/C ratio, glycogen depletion, and fibrosis were observed in the STZ group following Zn treatment (STZ+Zn). In the PCR analysis, the diabetic group's depleted CAT and HO-1 expressions were restored by Zn, with HO-1 levels increasing to above those of the control group (p0.999).Conclusion: In the diabetic liver of older animals, administration of a 5 mg/kg intraperitoneal Zn injection improved tissue morphology, normalized PGC1α expression, and strongly activated the enzymatic antioxidant defense (HO-1/CAT) at the genetic level, although it was unable to restore FTO protein levels.

Verified
Journal Article
Open access
PDF file
Omer UnalOmer Unal
Omer Unal
NÜNilüfer AKGÜN ÜNAL
Nilüfer AKGÜN ÜNAL
ETEmre Soner Tiryaki
Emre Soner Tiryaki
CACemile Avci-Akan
Cemile Avci-Akan
EMElif Gülbahçe Mutlu
Elif Gülbahçe Mutlu
ABAbdulkerim Kasim Baltaci
Abdulkerim Kasim Baltaci
This study investigates the neuroprotective effects of zinc sulfate (ZnSO4) against diabetic encephalopathy in an aged female rat model of Type 2 diabetes mellitus (T2DM). T2DM was induced using a 4-week high-fat diet followed by a single 25 mg/kg STZ injection. Diabetic rats were treated with 10 mg/kg/day ZnSO4 for 4 weeks. We evaluated serum lipids, hippocampal oxidative stress (MDA, GSH), gene expressions (SIRT-1, GLUT3, BDNF, Bax, Bcl-2), and structural injuries (Nissl, PAS, GAP43, NGF) in the hippocampus and cerebral cortex. Results demonstrated that ZnSO4 significantly ameliorated systemic dyslipidemia. In the diabetic hippocampus, ZnSO4 mitigated oxidative stress by decreasing MDA and elevating depleted GSH levels. Molecularly, ZnSO4 upregulated the suppressed expressions of SIRT-1, GLUT3, BDNF, and Bcl-2, while downregulating pro-apoptotic Bax. Histopathological and immunohistochemical findings confirmed that ZnSO4 reduced neuronal degeneration and vascular pathologies (PAS positivity), preserving neuroplasticity (elevated GAP43 and NGF) in both brain regions. In conclusion, ZnSO4 supplementation provides potent, multifaceted neuroprotection against T2DM-associated neurodegeneration by regulating systemic dyslipidemia, restoring redox homeostasis, activating the SIRT-1/BDNF anti-apoptotic pathway, and preserving structural integrity.

Verified
Journal Article
Open access
PDF file
AAAdem ATACAK
Adem ATACAK
EMElif Gülbahçe Mutlu
Elif Gülbahçe Mutlu
GAGözde ACAR
Gözde ACAR
SBSaltuk Bugra Baltaci
Saltuk Bugra Baltaci
RMRasim Mogulkoc
Rasim Mogulkoc
ABAbdulkerim Kasim Baltaci
Abdulkerim Kasim Baltaci
This study investigated the effects of zinc deficiency and supplementation on oxidative stress markers and the expression of ZnT3, NOGO-A, IL-6, and SESN2 in hippocampal tissue within a cuprizone (CPZ)-induced toxic demyelination model. Methods: Forty-six adult male Wistar rats were divided into five groups: Control (n = 6), Sham (n = 10), CPZ (n = 10), CPZ + zinc-deficient diet (n = 10), and CPZ + zinc supplementation (5 mg/kg/day, i.p., n = 10). Toxic demyelination was induced by continuous cuprizone administration for eight weeks. At the end of the experimental period, hippocampal malondialdehyde (MDA) and glutathione (GSH) levels were measured; additionally, hippocampal ZnT3, NOGO-A, IL-6, and SESN2 mRNA expression levels were analyzed using quantitative real-time PCR. Cuprizone administration led to significant hippocampal oxidative stress, characterized by increased MDA levels and decreased GSH concentrations (p < 0.05); these oxidative changes were further exacerbated in CPZ-treated animals fed a zinc-deficient diet (p < 0.05). Furthermore, CPZ-induced demyelination suppressed ZnT3 expression in hippocampal tissue while significantly increasing NOGO-A, IL-6, and SESN2 mRNA expression (p < 0.05). These molecular alterations were more pronounced in the zinc-deficient CPZ group (p < 0.05). Intraperitoneal zinc supplementation effectively mitigated these changes by suppressing oxidative stress, attenuating the upregulation of NOGO-A, IL-6, and SESN2 transcripts, and restoring ZnT3 expression to levels comparable to controls (p < 0.05). While dietary zinc deficiency exacerbated hippocampal oxidative stress, neuroinflammatory transcripts, and molecular markers associated with neurodegeneration in the cuprizone model, zinc supplementation restored oxidative balance; increased ZnT3 expression; and suppressed the upregulation of NOGO-A, IL-6, and SESN2. These findings suggest that zinc homeostasis significantly modulates cuprizone-induced hippocampal damage and that zinc supplementation may exert protective transcriptional and antioxidant effects during toxic demyelination.